|
End-of-day quote
Shanghai S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 6.320 CNY | +2.10% |
|
-14.48% | +83.19% |
| 10-13 | Harbin Pharmaceutical Subsidiary Gets China Approval for Sodium Sulfate API | MT |
| 08-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 15.92B 2.38B 2.11B 1.96B 1.78B 3.36B 226B 3.42B 23.56B 9.24B 118B 8.93B 8.74B 376B | P/E 2026 * |
26.3x | P/E 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 15.92B 2.38B 2.11B 1.96B 1.78B 3.36B 226B 3.42B 23.56B 9.24B 118B 8.93B 8.74B 376B | EV / Sales 2026 * |
0.97x | EV / Sales 2027 * | 0.94x |
| Free-Float |
48.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.10% | ||
| 1 week | -14.48% | ||
| Current month | -14.59% | ||
| 1 month | -14.13% | ||
| 3 months | +27.94% | ||
| 6 months | +43.64% | ||
| Current year | +83.19% |
| 1 week | 5.99 |  | 6.77 |
| 1 month | 5.99 | | 9.86 |
| Current year | 2.84 | | 9.86 |
| 1 year | 2.84 | | 9.86 |
| 3 years | 2.41 | | 9.86 |
| 5 years | 2.41 | | 9.86 |
| 10 years | 2.38 | | 9.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chuan You Lu
CEO | Chief Executive Officer | 64 | 2023-12-26 |
Xiao Dong Meng
DFI | Director of Finance/CFO | 54 | 2004-12-23 |
Kun Yu Ma
IRC | Investor Relations Contact | 45 | 2022-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Hua Li
BRD | Director/Board Member | 60 | 2021-01-07 |
Xiao Ping Hu
CHM | Chairman | 56 | 2023-12-26 |
Zhi Feng Sun
BRD | Director/Board Member | 46 | 2022-06-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/24 | Sell | 36,000 | 0.0014% | |||
| 7/1/24 | Sell | 27,000 | 0.0011% | |||
| 7/1/24 | Sell | Chief Financial Officer | 90,000 | 0.0036% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.10% | -14.48% | +74.10% | +78.53% | 2.38B | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,120B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 616B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 504B | |
| -0.13% | +5.98% | +32.91% | +50.39% | 367B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 360B | |
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | |
| -1.98% | +3.73% | -0.86% | +13.43% | 258B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 234B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 194B | |
| Average | +0.05% | +2.76% | +39.06% | +63.34% | 394.33B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.20% | +71.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.4B 2.45B 2.18B 2.02B 1.84B 3.47B 233B 3.52B 24.28B 9.52B 121B 9.2B 9B 387B | 16.94B 2.53B 2.25B 2.09B 1.9B 3.58B 240B 3.64B 25.07B 9.83B 125B 9.5B 9.3B 400B |
| Net income | 607M 90.67M 80.6M 74.71M 67.97M 128M 8.61B 130M 898M 352M 4.49B 340M 333M 14.32B | 699M 104M 92.85M 86.06M 78.3M 148M 9.91B 150M 1.03B 406M 5.17B 392M 384M 16.49B |
| Net Debt | - | - |
Employees
10,039
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | CN¥6.320 | +2.10% | 412,402,875 |
| 26-10-15 | CN¥6.190 | +0.49% | 377,389,544 |
| 26-10-14 | CN¥6.160 | -6.10% | 331,692,538 |
| 26-10-13 | CN¥6.560 | -1.35% | 530,218,805 |
| 26-10-12 | CN¥6.650 | -10.01% | 59,536,000 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.320CNY
Average target price
9.160CNY
Spread / Average Target
+44.94%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600664 Stock
Select your edition
All financial news and data tailored to specific country editions
